On November 26, 2019 Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense reported that Kineta’s management team has been invited to participate at 2nd Annual Evercore ISI HealthCONx Conference in Boston, MA (Press release, Kineta, NOV 26, 2019, https://kinetabio.com/2019/11/26/kineta-invited-to-participate-at-evercore-isihealthconx/ [SID1234553653]). Shawn Iadonato, Kineta Chief Executive Officer, will provide a corporate overview on Wednesday, December 4th at 3:50-4:10 PM, Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!